Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evogene Ltd. - Ordinary Shares (NQ:EVGN)

1.120 -0.150 (-11.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 862,219
Open 1.230
Bid (Size) 1.040 (11)
Ask (Size) 1.070 (3)
Prev. Close 1.270
Today's Range 1.050 - 1.240
52wk Range 0.9500 - 8.996
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual volume stocks in Tuesday's session
On Tuesday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
Stocks in Oversold Territory: EVGN, MLGO, PRSO, SHFS – More Undervalued Players Worth Watching Inside
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property

Performance

YTD
-42.3%
-42.3%
1 Month
-19.4%
-19.4%
3 Month
-38.1%
-38.1%
6 Month
-58.8%
-58.8%
1 Year
-82.8%
-82.8%

More News

Read More
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AI
Via Benzinga
Earnings Scheduled For November 21, 2024
Via Benzinga
A Glimpse of Evogene's Earnings Potential
Via Benzinga
Evogene Earnings Preview
Via Benzinga
Earnings Scheduled For March 6, 2025
Via Benzinga
Recap: Evogene Q3 Earnings
Via Benzinga
A Preview Of Evogene's Earnings
Via Benzinga
Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know
Via Benzinga
EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
Via Benzinga
Topics Cannabis
Exposures Cannabis
Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challenges
Via Benzinga
Topics Cannabis
Exposures Cannabis
Earnings Outlook For Evogene
Via Benzinga
Evogene's Casterra Gets $2.2M Orders To Supply Castor Seeds
Via Benzinga
Earnings Scheduled For March 7, 2024
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023
Via Benzinga
Why Evogene Shares Are Moving
Via Benzinga
Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Evogene Stock Is Tanking Today
Via Benzinga
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
TalkMarkets Announces Company Spotlight Featuring Evogene
Via TheNewswire.com

Frequently Asked Questions

Is Evogene Ltd. - Ordinary Shares publicly traded?
Yes, Evogene Ltd. - Ordinary Shares is publicly traded.
What exchange does Evogene Ltd. - Ordinary Shares trade on?
Evogene Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Evogene Ltd. - Ordinary Shares?
The ticker symbol for Evogene Ltd. - Ordinary Shares is EVGN on the Nasdaq Stock Market
What is the current price of Evogene Ltd. - Ordinary Shares?
The current price of Evogene Ltd. - Ordinary Shares is 1.120
When was Evogene Ltd. - Ordinary Shares last traded?
The last trade of Evogene Ltd. - Ordinary Shares was at 04/22/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.